Is Sorrento Therapeutics a Good Coronavirus Stock to Buy?

What do investors like to see after a stock doubles? How about another double? That's exactly what Sorrento Therapeutics (NASDAQ: SRNE) stock has done. It soared a little over 100% in 2020 and has doubled yet again so far in 2021.

Excitement about the biotech's COVID-19 programs has fueled this fantastic performance. But is Sorrento a good coronavirus stock to buy now?

Image source: Getty Images.

Continue reading

Source Fool.com